Exercise isn’t just good for the body; it’s increasingly clear it’s vital for brain health. Modern research from the University of California, San Francisco (UCSF) has pinpointed a surprising mechanism behind this connection: a liver enzyme released during physical activity that actively repairs aging blood vessels in the brain, ultimately bolstering memory. This discovery reframes how we understand exercise’s cognitive benefits, shifting focus from changes *within* brain cells to the protective barrier surrounding them.
For years, scientists have known that exercise improves cognitive function and helps ward off neurodegenerative diseases like Alzheimer’s. But the “how” remained elusive. The latest findings, published February 18 in the journal Cell, suggest that the benefits stem from a cascade of events beginning in the liver. As we age, the blood-brain barrier – a tightly packed network of vessels designed to shield the brain from harmful substances – becomes increasingly porous. This “leakiness” allows inflammatory compounds to enter brain tissue, contributing to cognitive decline. Researchers have now identified a key player in reversing this process.
The Role of GPLD1 and TNAP
The UCSF team, led by Dr. Saul Villeda, discovered that exercise triggers the liver to release an enzyme called GPLD1 into the bloodstream. This isn’t a new finding; the team first identified GPLD1’s brain-rejuvenating potential six years ago. Yet, the puzzle was that GPLD1 itself couldn’t cross the blood-brain barrier. The new research reveals that GPLD1 doesn’t *need* to enter the brain to exert its effects. Instead, it targets another protein, TNAP, which accumulates on the cells forming the blood-brain barrier as we age, contributing to its leakiness. GPLD1 essentially “trims” TNAP off these cells, tightening the barrier and restoring its protective function.
“This discovery shows just how relevant the body is for understanding how the brain declines with age,” said Villeda. “We’ve been looking at the brain in isolation for a long time, and this shows that what’s happening elsewhere in the body can have a huge impact on brain health.”
From Mouse Models to Potential Therapies
The research began with observations in mice. Older mice exhibited leakier blood-brain barriers, and tracking these leaks revealed a correlation between increased GPLD1 levels after exercise and improved barrier integrity. Young mice were then engineered to carry extra amounts of TNAP on their brain vessels, resulting in memory problems mimicking those seen in older animals. Conversely, older mice treated with extra GPLD1 showed a significant reduction in barrier leakiness and improved memory performance. The researchers found that reducing TNAP levels lowered brain inflammation and restored cognitive function.
Importantly, the team likewise tested a compound that lowered TNAP levels without directly increasing GPLD1. This approach yielded similar positive results, suggesting that targeting TNAP directly could be a viable therapeutic strategy. What we have is significant because it opens the possibility of mimicking the benefits of exercise for individuals who are unable to engage in regular physical activity.
Implications for Alzheimer’s Disease
The findings also have implications for understanding and potentially treating Alzheimer’s disease. Researchers observed that boosting GPLD1 levels in mice bred to develop Alzheimer’s-like plaques led to a reduction in those plaques within the hippocampus, a brain region crucial for memory. Human brain samples from older adults with Alzheimer’s disease also showed elevated levels of TNAP on blood vessels. While these findings don’t prove a causal link, they suggest that a compromised blood-brain barrier could contribute to the development and progression of the disease.
Large cohort studies have already established a correlation between higher levels of physical activity and a reduced risk of dementia, but proving causation has been challenging. This new research provides a biological mechanism that could explain this link. As Villeda noted, “It may open new therapeutic possibilities beyond the traditional strategies that focus almost exclusively on the brain.”
What’s Next?
While these findings are promising, further research is needed to determine the safety and efficacy of targeting TNAP in humans. UCSF scientists are now focused on testing the long-term effects of this approach and identifying other potential targets within the GPLD1 pathway. Before any drug reaches clinical trials, researchers must carefully assess potential risks and ensure that blocking TNAP doesn’t disrupt other essential bodily functions.
The study underscores the importance of maintaining a healthy lifestyle, including regular exercise, to protect brain health throughout life. While a pharmaceutical intervention may one day be available, the most accessible and proven strategy for bolstering brain function remains consistent physical activity.
Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute medical advice. We see essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
Have thoughts on this new research? Share your comments below, and please consider sharing this article with your network.
